π
Journal guidelines improve, but do not fix the problem of antibody validation. (Easy compliance through identifying information improves, but actual experimental validation is slow.)
See our analysis in a publication in PeerJ:
Hoek, J. M., Hepkema, W. M., & Halffman, W. (2020). The effect of journal guidelines on the reporting of antibody validation. PeerJ, 8, e9300. doi:10.7717/peerj.9300